Merit Medical Systems, Inc.

Fundamentals6.0
Price Action7.0
News Sentiment7.0
AI Rating
6.0

Key Drivers

  • Margin Strength
  • Strong Liquidity
  • Rich Valuation

AI
AI Summary

6.0

MMSI has shifted from a “cheap defensive compounder” to a quality-execution story priced for continued earnings and margin momentum, so with the stock already rerated sharply, investors should watch cash conversion and sustained margin expansion closely because the margin of safety is now thin.

EarningsMomentum
ValuationRisk
MedTech‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

6.0

Key Financial Insights:

  • Margin Strength
  • Strong Liquidity
  • Rich Valuation

MMSI shows solid profitability, liquidity, and cash generation with manageable leverage, but its premium valuation and heavy reliance on intangibles make the stock look expensive relative to its mid-single-digit return profile.

Profitability
PremiumValuation

Price Behavior

7.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Uptrend intact
  • Near resistance
  • Extended rally

MMSI remains in a strong uptrend after breaking out from the low-$70s to a new last month high near $91.20, but it is extended and needs a decisive close above resistance to confirm the move.

bullish
breakout
Support Level: $87.20-$87.70
Resistance Level: $91.20

Fast climb from $73.99 to $90.76 over the last month suggests short-term pullback risk

Sentiment & News

7.0

Key News Insights:

  • Earnings beat
  • Margin expansion
  • Guidance raised

Merit Medical's strong Q2 earnings beat, improved margins, and raised full-year guidance boosted sentiment, though softer cash flow and a stake reduction remain watchpoints.

EarningsBeat
GuidanceUp

The upbeat quarter and higher outlook should support near-term upside, but cash flow softness may temper the move